RESEARCH-USE BIOSIMILAR ANTIBODY

Levilimab

Monoclonal antibody · IgG1

BiocadIgG1RUO

Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid.

TARGETBiocad
YMonoclonal antibody
CATALOGSC-BS-431
CATALOG NUMBERSC-BS-431
MOLECULAR WEIGHTApprox. 145.7 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid.

Levilimab is a recombinant research-use antibody directed against Biocad.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Levilimab | StellaCyte